Inventor
LOGTENBERG TON
NL58 patents
⚠️ This page may combine multiple inventors who share the name “LOGTENBERG TON”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
MERUS NV
27 patentsUS9758805B2Sep 12, 2017
Methods and means for the production of Ig-like molecules
MERUS NV23 citations94
US10605808B2Mar 31, 2020
Antibody producing non-human animals
MERUS NV19 citations91
US9951124B2Apr 24, 2018
Antibody producing non-human mammals
MERUS NV10 citations91
US11279770B2Mar 22, 2022
Antibody that binds ErbB-2 and ErbB-3
MERUS NV7 citations85
US10752929B2Aug 25, 2020
Methods and means for the production of ig-like molecules
MERUS NV5 citations84
US10670599B2Jun 2, 2020
Method for selecting a single cell expressing a heterogeneous combination of antibodies
MERUS NV6 citations84
US10337045B2Jul 2, 2019
Methods and means for the production of Ig-like molecules
MERUS NV3 citations84
US10329596B2Jun 25, 2019
Methods and means for the production of Ig-like molecules
MERUS NV4 citations84
US11237165B2Feb 1, 2022
Antibody producing non-human animals
MERUS NV5 citations83
US10358492B2Jul 23, 2019
Bispecific IgG antibodies as T cell engagers
MERUS NV11 citations83
US10844127B2Nov 24, 2020
Antibodies that bind EGFR and ErbB3
MERUS NV8 citations82
US10647781B2May 12, 2020
Generation of binding molecules
MERUS NV6 citations82
US10934571B2Mar 2, 2021
Recombinant production of mixtures of antibodies
MERUS NV4 citations79
US12139548B2Nov 12, 2024
Antibody that binds ErbB-2 and ErbB-3
MERUS NV4 citations74
US12247078B2Mar 11, 2025
ERBB-2 and ERBB-3 binding bispecific antibodies for use in the treatment of cells that have an NRG1 fusion gene
MERUS NV3 citations73
US12123043B2Oct 22, 2024
Methods and means for the production of Ig-like molecules
MERUS NV1 citations73
US11926859B2Mar 12, 2024
Methods and means for the production of Ig-like molecules
MERUS NV2 citations73
US11780925B2Oct 10, 2023
ErbB-2 and ErbB3 binding bispecific antibodies for use in the treatment of cells that have an NRG1 fusion gene
MERUS NV5 citations73
US11820825B2Nov 21, 2023
Methods of treating a subject having an EGFR-positive and/or ErbB-3-positive tumor
MERUS NV2 citations71
US11753470B2Sep 12, 2023
Bispecific anti PD1-anti TIM3 antibodies
MERUS NV2 citations71
US11732043B2Aug 22, 2023
Antibodies that modulate a biological activity expressed by a cell
MERUS NV3 citations71
US11667714B2Jun 6, 2023
Binding molecules that modulate a biological activity expressed by a cell
MERUS NV3 citations71
US11408095B2Aug 9, 2022
Generation of binding molecules
MERUS NV2 citations71
US11559049B2Jan 24, 2023
Antibody producing non-human animals
MERUS NV2 citations70
US11939394B2Mar 26, 2024
Binding molecules that inhibit cancer growth
MERUS NV4 citations66
US11952424B2Apr 9, 2024
Multivalent antibody
MERUS NV1 citations62
US11785924B2Oct 17, 2023
Antibody producing non-human animals
MERUS NV0 citations62
MERUS B V
9 patentsUS9358286B2Jun 7, 2016
Methods and means for the production of IG-like molecules
MERUS B V100 citations98
US9248181B2Feb 2, 2016
Methods and means for the production of Ig-like molecules
MERUS B V95 citations98
US9248182B2Feb 2, 2016
Methods and means for the production of Ig-like molecules
MERUS B V73 citations98
US7927834B2Apr 19, 2011
Recombinant production of mixtures of antibodies
MERUS B V42 citations95
US9145588B2Sep 29, 2015
Generation of binding molecules
MERUS B V69 citations94
US7932360B2Apr 26, 2011
Recombinant production of mixtures of antibodies
MERUS B V41 citations94
US9765133B2Sep 19, 2017
Antibody producing non-human mammals
MERUS B V12 citations92
US9944695B2Apr 17, 2018
Antibody producing non-human mammals
MERUS B V8 citations83
US9908946B2Mar 6, 2018
Generation of binding molecules
MERUS B V6 citations82
CRUCELL HOLLAND BV
6 patentsUS7429486B2Sep 30, 2008
Recombinant production of mixtures of antibodies
CRUCELL HOLLAND BV82 citations97
US7262028B2Aug 28, 2007
Recombinant production of mixtures of antibodies
CRUCELL HOLLAND BV245 citations97
US7777010B2Aug 17, 2010
Use of a native epitope for selecting evolved binding members from a library of mutants of a protein capable of binding to said epitope
CRUCELL HOLLAND BV29 citations93
US6858384B2Feb 22, 2005
Phage antibodies
CRUCELL HOLLAND BV25 citations93
US7901919B2Mar 8, 2011
Chimaeric phages
CRUCELL HOLLAND BV26 citations92
US7329530B2Feb 12, 2008
Chimaeric phages
CRUCELL HOLLAND BV33 citations92
LOGTENBERG TON
3 patentsMERUS BIOPHARMACEUTICALS B V I O
1 patentBECTON DICKINSON CO
1 patentVAN BERKEL PATRICIUS H C
1 patentU BISYS BV
1 patentHOOGENBOOM HENDRICUS RENERUS
1 patentShowing the top 50 of 58 patents by PatentIndex Score.